Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Products & comparisons
Product source

Lipo Spermidine capsule label record from Renue By Science in DSLD

The NIH DSLD record lists Lipo Spermidine from Renue By Science as a capsule declaring 8 mg spermidine trihydrochloride per labelled serving. A database listing is not evidence of efficacy, safety or approval. [1]

Automatic summary · not editorially reviewed

Label · NIH DSLD
Lipo SpermidineOriginal label · NIH DSLD
Lipo Spermidine

FROM THE ORIGINAL LABEL

A closer look at the product

Pack contents
90 Vegetarian Capsule(s)
Label serving
2 Vegetarian Capsule(s)
Servings per container
45
Barcode / SKU
6 56165 99690 2
Open original label (PDF)
Ingredients & declared amounts1

Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.

IngredientAmountPer label serving
Spermidine Trihydrochloride8 mg2 Vegetarian Capsule(s)

Other ingredients: D-Ribose, Sunflower Lecithin, Rice Flour, Microcrystalline Cellulose

Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.

The key findings

  1. DSLD record 319024 lists the label name Lipo Spermidine, brand Renue By Science, entered 2024-09-25. [1]

  2. The label declares capsule form and spermidine trihydrochloride 8 mg per labelled serving. [1]

  3. DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. [1]

The source at a glance

Brand
Renue By Science
Form
Capsule
Pack contents
90 Vegetarian Capsule(s)
Label serving
2 Vegetarian Capsule(s)
Ingredients listed
Spermidine Trihydrochloride
Record type / format
Dietary supplement label/database record (DSLD), not a study.
Scope / context
The described product: Lipo Spermidine capsules from Renue By Science, not a patient population.
Summary based on
Product label / database record

Lipo Spermidine record in the NIH DSLD

This is a label record in the Dietary Supplement Label Database of the NIH Office of Dietary Supplements, record 319024. The label name is Lipo Spermidine and the declared brand is Renue By Science. The label entered the database on 2024-09-25; the source notes this is not a product launch date. The record describes label declarations only.

Supporting source [1]

Declared capsule form and 8 mg ingredient amount

The physical form on the label is capsule, and the DSLD category is Non-Nutrient/Non-Botanical. The declared ingredient is spermidine trihydrochloride at 8 mg per labelled serving. This amount is a label fact, not personal dosing advice. No independent testing, price or batch certificate is supplied by this record.

Supporting source [1]

What the DSLD listing does not establish

Inclusion in DSLD does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. The record is a snapshot of label declarations, not a study or an endorsement. It does not show that the product affects aging biology or any health outcome.

Supporting source [1]

How to interpret this

Product label record; not evidence of efficacy or approval. It is a snapshot of label declarations only, with no independent testing, price or batch certificate.

Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.

Source & supporting passages

[1]
Lipo Spermidine

Renue By Science · dsld.od.nih.gov

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Product label name: Lipo Spermidine
  2. Finding 2 ↑

    Spermidine Trihydrochloride: 8 mg per labelled serving
  3. Finding 3 ↑

    DSLD inclusion does not establish efficacy, safety,

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…